The FDA has approved subcutaneous tocilizumab for treating active systemic juvenile idiopathic arthritis in pediatric patients as young as 2 years old…

The FDA has approved subcutaneous tocilizumab for treating active systemic juvenile idiopathic arthritis in pediatric patients as young as 2 years old…
Paula Marchetta, MD, MA, MBA, became a member of the ACR in 1989, during her rheumatology fellowship at Bellevue Hospital and the New York University (NYU) Medical Center. Just 10 years earlier, rheumatology had been an unlikely path. Dr. Marchetta—with a love of the arts—was pursuing Bachelor’s and Master’s degrees in English. But she found…
Thomas R. Collins |
CHICAGO—ACR leaders described a series of looming legislative and regulatory threats to rheumatologists and their patients—including the proposed collapsing of evaluation and management (E/M) coding and potential changes to step therapy rules—and urged everyone in the field to make their voices heard to quash the proposals. They also recounted recent victories in the policy realm…
According to new data, BMS-986165, an oral, selective tyrosine kinase 2 inhibitor, may be safe and effective for treating plaque psoriasis…
CHICAGO—Christina H. Opava, PhD, RPT, is the recipient of the 2018 ARHP Lifetime Achievement Award, which was presented (along with the other ACR and ARHP awards) during the opening session of the 2018 ACR/ARHP Annual Meeting on Oct. 20. “Receiving this award is an immense honor,” she tells The Rheumatologist. “My first thought was that…
“You’re probably going to die tonight. You should call your family.” Jonathan Koch, president and CCO of Asylum Entertainment LLC, told his touching and inspiring story of mysterious illness, resilience and recovery in the keynote presentation of the 2018 ACR/ARHP Annual Meeting.
Jill Johnson, MD |
You are seeing a hospital consult late in the afternoon on a Saturday. The patient has suspected, new-onset lupus with inflammatory arthritis, renal failure with nephrotic range proteinuria and a malar rash. You plan to start the patient on high-dose IV steroids, and you decide to speak to the nephrologist on call first. When he…
“I think I’m mentally sharper when I have been exercising and taking care of myself,” says Chris Phillips, MD, a rheumatologist in solo practice in Paducah, Ky. Dr. Phillips has recognized these benefits since high school, when he began participating in competitive sports. Four years ago, Dr. Phillips was competing against 40 other cyclists in…
Canadian Pediatric Rheumatologist Invested into Order of Canada Peter Dent, MD, professor emeritus of pediatrics at McMaster University in Hamilton, Ontario, Canada, was invested into the Order of Canada in May. The Order of Canada is the country’s highest civilian honor. “Dr. Dent has had a substantial positive impact on healthcare, in Hamilton and far…
Severe infections occurred in 25% of patients with anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis (AAV) who were treated with rituximab, according to results of an observational study conducted in the United Kingdom (U.K.) and Austria. Trimethoprim-sulfamethoxazole (TMP/SMX) prophylaxis, however, reduced the risk of severe infections, the investigators reported in Annals of the Rheumatic Diseases.1 Andreas…